Table 4.
ST59 (n = 36), Ra (%) | Non-ST59 (n = 44), R (%) | P- valueb | |
---|---|---|---|
CFZ | 100 | 100 | |
LZD | 0 | 0 | |
CIP | 0 | 15.9 | <0.05 |
DA | 94.4 | 68.1 | <0.01 |
E | 97.2 | 70.5 | <0.01 |
SXT | 0 | 18.2 | <0.01 |
MOF | 0 | 6.8 | >0.05 |
FD | 0 | 0 | |
V | 0 | 0 | |
TET | 36.1 | 29.5 | >0.05 |
P | 100 | 100 | |
RD | 0 | 4.5 | >0.05 |
LEV | 0 | 9.1 | >0.05 |
AMP | 100 | 100 | |
GM | 0 | 6.8 | >0.05 |
Q/D | 0 | 0 | |
TGC | 0 | 0 |
R, Resistance.
The resistance rates of antimicrobials among ST59 were compared with those among non-ST59 isolates.